Adagio Therapeutics, Inc. (ADGI): Price and Financial Metrics
ADGI Price/Volume Stats
Current price | $4.64 | 52-week high | $78.82 |
Prev. close | $4.60 | 52-week low | $2.41 |
Day low | $4.40 | Volume | 536,300 |
Day high | $4.74 | Avg. volume | 2,269,922 |
50-day MA | $4.13 | Dividend yield | N/A |
200-day MA | $6.92 | Market Cap | 504.98M |
ADGI Stock Price Chart Interactive Chart >
Adagio Therapeutics, Inc. (ADGI) Company Bio
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts.
ADGI Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | -75.87% |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | 0.00% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...